News and Announcements
Australian cryptocurrency company Bit Trade launch crowdfunding campaign to raise $3 million
- Published November 25, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Cryptocurrency company Bit Trade Limited is raising $3 million via crowdfunding campaign.
- Funds raised through the campaign will be used for strategic growth and international expansion.
- The campaign was launched via the Equitise platform.
Bit Trade Limited have launched their crowdfunding campaign with the aim to raise $3 million.
The company is in full growth mode and the crowdfunding campaign provides the opportunity to invest in the future of cryptocurrency.
Equity crowdfunding allows traders to buy a share in companies and companies to raise funds from a wider variety of people.
The company plan to use the funds raised for strategic growth and international expansion.
This equity crowdfunding campaign is the first time in Australia that everyday investors can be involved in shaping the future of wealth as Bit Trade are at the forefront of the smart securities market.
In 2017 $5.9 billion was traded in cryptocurrencies by Australians.
Bit Trade is an established digital currency exchange with a dynamic team of entrepreneurs and experts in financial markets and blockchain technology.
We believe blockchain and digital currencies are the future of investment, and our mission is to empower customers by providing them the tools and knowledge to develop and trade these new blockchain based assets.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
